With the Centre’s nod for its bio-technology and pharma special economic zone (SEZ) in Hyderabad, the Delhi-based realty major Parsvnath Developers Ltd (PDL) is upbeat about its SEZ business.
The company has already set aside funds of around Rs 40,000 crore for at least 12 of its 15 proposed SEZs. However, the company is now mulling other options to fund the projects.
Although, PDL has a history of funding its projects mostly through internal accruals, its managing director Sanjeev Jain doesn’t rule out the possibility of getting PDL’s subsidiary Parsvnath SEZ listed to fund the SEZ projects.
Parsvnath has received a formal approval for four of its SEZs and in-principle approval to other eight. Apart from the Kancheepuram multi-product SEZ, all other SEZs would be product-specific.
Read more in The Business Standard article.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment